Empagliflozin is an important antidiabetic drug used for the treatment of type 2 diabetes. It works by selectively and reversibly inhibiting SGLT2 (sodium-glucose cotransporter 2) present in the proximal convoluted tubule of kidneys. SGLT2 is responsible for reabsorbing around 90% of the filtered glucose back into the bloodstream. By blocking this transporter, Empagliflozin prevents the
Empagliflozin is a prescription medicine used to treat type 2 diabetes. Type 2 diabetes is a condition where the body does not make enough insulin, or the insulin that it makes does not work properly. This can cause high blood sugar levels (hyperglycemia). It may be prescribed if diet and exercise alone are not enough
Dapagliflozin is an oral anti-diabetic medication belonging to the sodium-glucose cotransporter-2 (SGLT2) inhibitors drug class. Approved by the FDA, it is an important therapeutic option for managing blood glucose levels in patients with type 2 diabetes. As an SGLT2 inhibitor, dapagliflozin works by blocking the SGLT2 transporter in kidney tubules. The novel mechanism of action
We are thrilled to express our heartfelt gratitude for the success of our recent inauguration ceremony, which took place on November 5th. It was a momentous occasion that marked a new chapter for our organization. We would like to extend our sincere appreciation to the esteemed dignitaries who graced the event with their presence: Mr.
The success of our recent inauguration ceremony. Read More »
